4-IpomeanolAlternative Names: NSC 349438
Latest Information Update: 06 Sep 2011
At a glance
- Originator National Cancer Institute (USA)
- Class Antineoplastics; Furans; Small molecules; Terpenes
- Mechanism of Action Apoptosis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hepatocellular carcinoma; Non-small cell lung cancer